A citation-based method for searching scientific literature

Anne Laure Giraudet, Abir Al Ghulzan, Anne Aupérin, Sophie Leboulleux, Ahmed Chehboun, Frédéric Troalen, Clarisse Dromain, Jean Lumbroso, Eric Baudin, Martin Schlumberger. Eur J Endocrinol 2008
Times Cited: 150







List of co-cited articles
906 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
988
59

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
Jacques Barbet, Loïc Campion, Françoise Kraeber-Bodéré, Jean-François Chatal. J Clin Endocrinol Metab 2005
227
57

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli,[...]. J Clin Oncol 2012
877
45

Cabozantinib in progressive medullary thyroid cancer.
Rossella Elisei, Martin J Schlumberger, Stefan P Müller, Patrick Schöffski, Marcia S Brose, Manisha H Shah, Lisa Licitra, Barbara Jarzab, Viktor Medvedev, Michael C Kreissl,[...]. J Clin Oncol 2013
685
37

Medullary thyroid cancer: management guidelines of the American Thyroid Association.
Richard T Kloos, Charis Eng, Douglas B Evans, Gary L Francis, Robert F Gagel, Hossein Gharib, Jeffrey F Moley, Furio Pacini, Matthew D Ringel, Martin Schlumberger,[...]. Thyroid 2009
823
31

Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
Andreas Machens, Henning Dralle. J Clin Endocrinol Metab 2010
160
29

Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis.
Johannes A A Meijer, Saskia le Cessie, Wilbert B van den Hout, Job Kievit, Johannes W Schoones, Johannes A Romijn, Johannes W A Smit. Clin Endocrinol (Oxf) 2010
95
30

Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine.
E Modigliani, R Cohen, J M Campos, B Conte-Devolx, B Maes, A Boneu, M Schlumberger, J C Bigorgne, P Dumontier, L Leclerc,[...]. Clin Endocrinol (Oxf) 1998
358
27


Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.
Rossella Elisei, Barbara Cosci, Cristina Romei, Valeria Bottici, Giulia Renzini, Eleonora Molinaro, Laura Agate, Agnese Vivaldi, Pinuccia Faviana, Fulvio Basolo,[...]. J Clin Endocrinol Metab 2008
327
24

Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.
Andreas Machens, Ulrich Schneyer, Hans-Jürgen Holzhausen, Henning Dralle. J Clin Endocrinol Metab 2005
173
23

Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
Anne Laure Giraudet, Daniel Vanel, Sophie Leboulleux, Anne Aupérin, Clarisse Dromain, Linda Chami, Noël Ny Tovo, Jean Lumbroso, Nathalie Lassau, Guillaume Bonniaud,[...]. J Clin Endocrinol Metab 2007
150
20

Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.
Samuel A Wells, Jessica E Gosnell, Robert F Gagel, Jeffrey Moley, David Pfister, Julie A Sosa, Michael Skinner, Annetta Krebs, James Vasselli, Martin Schlumberger. J Clin Oncol 2010
352
20

Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Claudia Scollo, Eric Baudin, Jean-Paul Travagli, Bernard Caillou, Nicolas Bellon, Sophie Leboulleux, Martin Schlumberger. J Clin Endocrinol Metab 2003
231
19

Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.
Razelle Kurzrock, Steven I Sherman, Douglas W Ball, Arlene A Forastiere, Roger B Cohen, Ranee Mehra, David G Pfister, Ezra E W Cohen, Linda Janisch, Forlisa Nauling,[...]. J Clin Oncol 2011
416
19

Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma.
A Miyauchi, T Onishi, S Morimoto, S Takai, F Matsuzuka, K Kuma, M Maeda, Y Kumahara. Ann Surg 1984
85
22

Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.
Martin J Schlumberger, Rossella Elisei, Lars Bastholt, Lori J Wirth, Renato G Martins, Laura D Locati, Barbara Jarzab, Furio Pacini, Chantal Daumerie, Jean-Pierre Droz,[...]. J Clin Oncol 2009
257
18

Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer.
Elaine T Lam, Matthew D Ringel, Richard T Kloos, Thomas W Prior, Michael V Knopp, Jiachao Liang, Steffen Sammet, Nathan C Hall, Paul E Wakely, Vasyl V Vasko,[...]. J Clin Oncol 2010
276
18

Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging.
G Pellegriti, S Leboulleux, E Baudin, N Bellon, C Scollo, J P Travagli, M Schlumberger. Br J Cancer 2003
88
20


New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
15

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
Rossella Elisei, Valeria Bottici, Fabiana Luchetti, Giancarlo Di Coscio, Cristina Romei, Lucia Grasso, Paolo Miccoli, Pietro Iacconi, Fulvio Basolo, Aldo Pinchera,[...]. J Clin Endocrinol Metab 2004
288
14

Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series.
Raffaele Ciampi, Caterina Mian, Laura Fugazzola, Barbara Cosci, Cristina Romei, Susi Barollo, Valentina Cirello, Valeria Bottici, Giulia Marconcini, Pelizzo Maria Rosa,[...]. Thyroid 2013
109
14

Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS.
Nishant Agrawal, Yuchen Jiao, Mark Sausen, Rebecca Leary, Chetan Bettegowda, Nicholas J Roberts, Sheetal Bhan, Allen S Ho, Zubair Khan, Justin Bishop,[...]. J Clin Endocrinol Metab 2013
147
14

Chemoembolization for liver metastases from medullary thyroid carcinoma.
J Fromigué, T De Baere, E Baudin, C Dromain, S Leboulleux, M Schlumberger. J Clin Endocrinol Metab 2006
62
20


Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.
Andreas Machens, Jörg Ukkat, Steffen Hauptmann, Henning Dralle. Arch Surg 2007
68
19

Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma.
Elizabeth Fox, Brigitte C Widemann, Meredith K Chuk, Leigh Marcus, Alberta Aikin, Patricia O Whitcomb, Maria J Merino, Maya Lodish, Eva Dombi, Seth M Steinberg,[...]. Clin Cancer Res 2013
96
13

2012 European thyroid association guidelines for metastatic medullary thyroid cancer.
M Schlumberger, L Bastholt, H Dralle, B Jarzab, F Pacini, J W A Smit. Eur Thyroid J 2012
88
14

A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer.
Martin Schlumberger, Barbara Jarzab, Maria E Cabanillas, Bruce Robinson, Furio Pacini, Douglas W Ball, Judith McCaffrey, Kate Newbold, Roger Allison, Renato G Martins,[...]. Clin Cancer Res 2016
138
13

Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels.
Seng C Ong, Heiko Schöder, Snehal G Patel, Ida M Tabangay-Lim, Indukala Doddamane, Mithat Gönen, Ashok R Shaha, R Michael Tuttle, Jatin P Shah, Steven M Larson. J Nucl Med 2007
110
12

Medullary thyroid carcinoma.
F Pacini, M G Castagna, C Cipri, M Schlumberger. Clin Oncol (R Coll Radiol) 2010
134
12

Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma.
Hans H G Verbeek, John T M Plukker, Klaas Pieter Koopmans, Jan Willem B de Groot, Robert M W Hofstra, Anneke C Muller Kobold, Anouk N A van der Horst-Schrivers, Adrienne H Brouwers, Thera P Links. J Nucl Med 2012
59
20

Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer.
Bruce G Robinson, Luis Paz-Ares, Annetta Krebs, James Vasselli, Robert Haddad. J Clin Endocrinol Metab 2010
181
12

High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas.
Margarida M Moura, Branca M Cavaco, António E Pinto, Valeriano Leite. J Clin Endocrinol Metab 2011
153
12

Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
Giuseppe Costante, Domenico Meringolo, Cosimo Durante, Davide Bianchi, Maria Nocera, Salvatore Tumino, Umberto Crocetti, Marco Attard, Marianna Maranghi, Massimo Torlontano,[...]. J Clin Endocrinol Metab 2007
205
11


Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
H Donis-Keller, S Dou, D Chi, K M Carlson, K Toshima, T C Lairmore, J R Howe, J F Moley, P Goodfellow, S A Wells. Hum Mol Genet 1993
11

Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.
Laurie L Carr, David A Mankoff, Bernardo H Goulart, Keith D Eaton, Peter T Capell, Elizabeth M Kell, Julie E Bauman, Renato G Martins. Clin Cancer Res 2010
287
11

Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.
Dana T Yip, Maria Hassan, Kalliopi Pazaitou-Panayiotou, Daniel T Ruan, Atul A Gawande, Randall D Gaz, Francis D Moore, Richard A Hodin, Antonia E Stephen, Peter M Sadow,[...]. Surgery 2011
37
29


Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety.
Caterina Mian, Michela Perrino, Carla Colombo, Elisabetta Cavedon, Gianmaria Pennelli, Stefano Ferrero, Simone De Leo, Cristiano Sarais, Chiara Cacciatore, Gloria Irene Manfredi,[...]. J Clin Endocrinol Metab 2014
57
19

Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.
Samuel A Wells, Furio Pacini, Bruce G Robinson, Massimo Santoro. J Clin Endocrinol Metab 2013
184
11

Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.
Akira Miyauchi, Takumi Kudo, Akihiro Miya, Kaoru Kobayashi, Yasuhiro Ito, Yuuki Takamura, Takuya Higashiyama, Mitsuhiro Fukushima, Minoru Kihara, Hiroyuki Inoue,[...]. Thyroid 2011
161
11

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
11

Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.
Reese W Randle, Courtney J Balentine, Glen E Leverson, Jeffrey A Havlena, Rebecca S Sippel, David F Schneider, Susan C Pitt. Surgery 2017
97
11

Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
R Cohen, J M Campos, C Salaün, H M Heshmati, J L Kraimps, C Proye, E Sarfati, J F Henry, P Niccoli-Sire, E Modigliani. J Clin Endocrinol Metab 2000
163
10

Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature.
José Miguel Dora, Maria Heloisa Busi da Silva Canalli, Clarissa Capp, Márcia Khaled Puñales, José Gilberto H Vieira, Ana Luiza Maia. Thyroid 2008
37
27

Guidelines for diagnosis and therapy of MEN type 1 and type 2.
M L Brandi, R F Gagel, A Angeli, J P Bilezikian, P Beck-Peccoz, C Bordi, B Conte-Devolx, A Falchetti, R G Gheri, A Libroia,[...]. J Clin Endocrinol Metab 2001
10

Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control.
J Brierley, R Tsang, W J Simpson, M Gospodarowicz, S Sutcliffe, T Panzarella. Thyroid 1996
159
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.